Frost & Sullivan Recognizes Novotech as 2025 Global Biotech CRO Company of the Year
In recognition of its innovation, client-focused delivery, and global impact, Novotech has been awarded the 2025 Global Biotechnology Contract Research Organization (CRO) Company of the Year by Frost & Sullivan.
Share
Novotech is a globally recognized full-service clinical CRO and scientific advisory firm, trusted by biotech and small- to mid-sized pharmaceutical companies to advance their drug development programs at every phase. With a global footprint spanning Asia-Pacific, North America, and Europe, Novotech supports over 5,000 clinical trial sites and a distributed team of experts delivering seamless, end-to-end solutions across geographies.
'Novotech is redefining biotech-focused clinical research through AI-driven innovation, global expansion, and a client-embedded partnership model. With a clear vision to be the CRO of choice for small to mid-size biotech, Novotech leverages deep therapeutic expertise and regional agility to deliver speed, flexibility, and transformative impact in clinical trials.'
— Unmesh Lal, Vice President – Healthcare & Life Sciences, Frost & Sullivan
According to Frost & Sullivan, Novotech's client-first approach, coupled with its scale and scientific capabilities, continues to set it apart in the biotech CRO space. The firm's deep therapeutic expertise in oncology, rare diseases, infectious diseases, and advanced modalities—such as gene therapies and RNA-based treatments—was cited as a key differentiator.
The award also acknowledged Novotech's ability to maintain trial continuity and delivery excellence amid geopolitical, operational, and economic volatility. Strategic use of AI-enabled tools, predictive analytics, and real-time data platforms further enables Novotech to accelerate timelines and improve decision-making for biotech sponsors.
'We're honored by Frost & Sullivan's recognition, which highlights Novotech's strategic focus on delivering regional expertise through a global model to support biotech and mid-size pharma sponsors. It also reflects the strength of our teams in driving operational, scientific, and client delivery excellence worldwide.'
— Dr. John Moller, CEO, Novotech
Unmesh Lal added: 'Frost & Sullivan believes Novotech's road ahead is about growing without losing its soul: scaling globally while staying deeply connected to biotech clients, preserving its cultural DNA, and delivering the high-touch, high-value service that has become its hallmark.'
The award was accepted on behalf of Novotech by Scott Schliebner, Vice President of Drug Development Consulting, during the Frost & Sullivan Excellence in Best Practices Awards Gala held in Los Angeles, California, on June 26.
About Novotech Novotech-CRO.com
Novotech is a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase.
With a global footprint that includes 30+ offices across the Asia-Pacific region, North America, and Europe and partnerships with 5,000+ trial sites, Novotech provides clients an accelerated path to bring life-changing therapies to market by providing access to key clinical trial destinations and diverse patient populations.
Through its client-centric service model, Novotech seamlessly integrates people, processes, and technologies to deliver customized solutions that accelerate the path to market for life-changing therapies. By adopting a true partnership approach, Novotech shares a steadfast commitment to client success, empowering innovation, and advancing healthcare worldwide.
Recipient of numerous industry accolades, including the Frost & Sullivan CRO Company of the Year award for 19 consecutive years, Novotech is recognized for its excellence in clinical trial execution and innovation. Its deep therapeutic and regulatory expertise, combined with local market insights, ensures streamlined clinical trials, optimized data analytics, and accelerated patient recruitment strategies.
Together with clients, Novotech transforms scientific advancements into therapies that improve global health outcomes, embodying a mission of driving innovation and delivering impactful results.
For more information or to speak to an expert team member visit www.Novotech-CRO.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
24 minutes ago
- Business Wire
EdgeCortix Completes Initial Close of Series B Financing, Driving Total Funding to Nearly $100 Million USD
TOKYO--(BUSINESS WIRE)-- EdgeCortix® Inc., a leading fabless semiconductor company specializing in energy-efficient artificial intelligence (AI) processing at the edge, today announced the initial close of its Series B funding round. This milestone raises EdgeCortix's cumulative funding, including equity investments and substantial non-dilutive government awards since December 2024, to nearly $100 million USD, marking significant momentum in the company's rapid growth and global market expansion. This Series B round attracted substantial interest from prominent global investors, highlighting continued confidence in EdgeCortix's innovative AI technologies, strategic leadership, and robust customer traction. Investors participating in the initial close include Yanmar Ventures, Pacific Bays Capital, NTT Finance Corporation, SiC Power, and Aero X Ventures, along with continued support from existing investors including SBI Investments and Global Hands-On VC (GHOVC). 'The strong support from both new and existing investors is a clear endorsement of our market position and proven success across sectors such as robotics, industrial automation, defense, aerospace, and space exploration,' said Dr. Sakyasingha Dasgupta, Founder and CEO of EdgeCortix. 'This funding empowers us to accelerate the mass-production deployment of our highly successful SAKURA-II AI co-processors, which have secured design-wins across multiple industries. Additionally, it fuels the rapid production of our next-generation SAKURA-X chiplet platform, offering an unprecedented performance of up to 2,000 TOPS per device, with low-power, enabling advanced generative AI workloads in scalable high-performance physical AI systems.' Investor Perspectives: 'We are truly honored to have the opportunity to participate in the investment in EdgeCortix. We believe that the innovative technologies developed by EdgeCortix are closely aligned with Yanmar Ventures' mission to support game-changing solutions that help shape a better future. Through this investment, we look forward to exploring potential collaborations and working together to create value that can be returned to society,' commented Sota Tsutsuki, Senior Capitalist, Yanmar Ventures Co., Ltd. 'We see tremendous potential in EdgeCortix's unique technology, forward-looking market strategy, and proven execution. These strengths position the company to drive meaningful growth in industrial automation, telecommunications, aerospace, and beyond,' added Seiichi Hashimoto, Senior Vice President, Executive Manager, Group Treasury Department, NTT Finance Corporation. 'EdgeCortix is uniquely positioned through the dual-use nature of its technology, underscored by its recent high-profile project award from the U.S. Defense Innovation Unit,' said Maxwell Imai Weiss, Partner, Pacific Bays Capital. 'We see strong potential for significant impact and accelerated growth opportunities across defense, aerospace, and space applications, as well as broader commercial markets,' added Dr. Jason Nye, Partner, Pacific Bays Capital. 'EdgeCortix is exactly what we look for at Aero X Ventures - proven dual-use technology with real traction. They've built energy-efficient AI processors that work across defense, aerospace, and commercial markets, and they're actually winning customers and government contracts. Their recent Defense Innovation Unit award speaks volumes about the strategic value of what they're building,' Management Team, Aero X Ventures. ' Since our initial investment in 2023, EdgeCortix has achieved extraordinary progress. Under the visionary leadership of CEO Dr. Sakyasingha Dasgupta, the team has consistently demonstrated remarkable execution capabilities. This new round of funding will further accelerate their exponential growth - continuous acquisition of new customers, the next generation products development, and keep attracting top-tier talent,' said Ken Yasunaga, Managing Partner, Global Hands-On VC. The Series B funding round remains open, with additional closings anticipated throughout 2025 as global investor interest continues. About EdgeCortix Inc. EdgeCortix is driving innovation in semiconductor solutions for the connected intelligent edge. Established in 2019 and headquartered in Tokyo, Japan, with additional offices in the United States and India, EdgeCortix develops silicon-based, energy-efficient AI processors purpose-built for Generative AI workloads at the edge. The company's patented hardware-software co-design methodology enables highly efficient runtime-reconfigurable AI accelerators, delivering industry-leading performance-per-watt for edge inference across defense, aerospace, smart cities, Industry 4.0, robotics and telecommunications applications.
Associated Press
an hour ago
- Associated Press
ComEd Restores Power to 80 Percent of Customers Impacted by Pair of Weekend Storms
CHICAGO--(BUSINESS WIRE)--Aug 17, 2025-- Following two rounds of storms that both included high winds of up to 70 mph across all of northern Illinois Saturday and Sunday, ComEd crews have restored power to more than 80 percent of impacted customers. Some of the hardest hit areas from this afternoon's storms included Crystal Lake, DeKalb, Joliet, Mount Prospect, Rockford, and Skokie. Approximately 40,000 customers remain without power as of 10 a.m. Sunday. Over 500 ComEd crews are deployed throughout the region and will soon be joined by 33 additional crews Sunday afternoon. All crews will continue to work around the clock to restore service to all remaining customers as quickly and safely as possible. Based on storms of similar magnitude, ComEd expects power to be restored to nearly all of these customers by 2 p.m. Monday. When responding to power outages caused by storms, ComEd's priority is to restore critical facilities such as police and fire stations, nursing homes and hospitals first, followed by repairs that will restore power to the greatest number of customers. 'Safely restoring power to all our customers impacted by this weekend's storms remains our number one priority, and our dedicated crews are working around the clock to bring all affected customers back,' said David Perez, executive vice president and COO of ComEd. 'We recognize that losing power at any time can be frustrating, and we appreciate our customers' patience as we continue to assess damage throughout the region and restore power.' Climate change has increased the frequency and intensity of severe weather. ComEd has been investing in power grid upgrades and tree trimming to minimize the impact of storms. Since smart grid upgrades began in 2011, ComEd has avoided more than 24.7 million power outages and improved overall reliability by more than 57 percent. In 2024, ComEd was named most reliable utility in the Midwest. Public safety is paramount, and ComEd encourages customers to take the following precautions: ComEd urges customers to contact the company immediately if they experience a power outage. Customers can text OUT to 26633 (COMED) to report an outage and receive restoration information and can follow the company on Twitter @ComEd or on Facebook at Customers can also call 800 EDISON1 (800-334-7661), or report outages via the website at Spanish-speaking customers should call 800-95-LUCES (800-955-8237). With ComEd's new Outage Tracker, customers can report outages, check estimated time of restoration, view crew status updates, and explore our outage map. Visit ComEd's mobile app for iPhone and Android® smart phones gives customers the ability to report power outages and manage their accounts; download the app at source version on CONTACT: ComEd Media Relations 312-394-3500 KEYWORD: UNITED STATES NORTH AMERICA ILLINOIS INDUSTRY KEYWORD: UTILITIES ENERGY SOURCE: ComEd Copyright Business Wire 2025. PUB: 08/17/2025 04:13 PM/DISC: 08/17/2025 04:13 PM
Business Wire
a day ago
- Business Wire
FUN Investors Have Opportunity to Join Six Flags Entertainment Corporation Fraud Investigation With the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)-- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Six Flags Entertainment Corporation ('Six Flags' or 'the Company') (NYSE: FUN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Six Flags announced its Q2 2025 financial results on August 6, 2025. The Company swung from a profit to a $100 million dollar loss for the quarter, and cut its full year guidance. The Company blamed bad weather for the downturn but also indicated lower sales of season passes contributed to poor results. Finally, the Company's CEO will step down at the end of the year. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at or by email at bschall@ The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
